4Issemann I,Green S．Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators[J]．Nature，1990；347(6294)：645-650.
5Deeb SS．Fajas L，Nemoto M，et al.A Pro12 Ala substitution in PPARγ2 associated with decreased receptor activity lower boby index and impaired insulin sensitivity[J].Nat Genet．1998：20：284-287.
6Hara K,Okada T，Tobe K，et al．The Pro12Ala polymorphism in PPAR gamma 2 may confer resistance to type 2 diabetes[J]．Biochem Biophys Res Commun，2001；271：212-216.
7Douglas JA，Erdos MR，Waranabe RM，et al.The peroxisome proliferator-activated receptor-γ2 Pro12Ala variant:association with type 2 diabetes and trait differences [J]．Diabetes，2001；50：886-889.
8Moon MK，Cho YM，Jung HS,et al.Genetic polymorphisms in peroxisome proliferator-activated receptor gamma are associated with type 2 diabetes mellitus and obesity in the Korean population[J]．Diabet Med,2005；22(9)：1161-1166.
9Doney AS．Fischer B，Cecil JE，et al．Association of the Pro12Ala and C1431T variants of PPARγ and their haplotypes with susceptibility to Type 2 diabetes[J]．Diabetologia，2004；47(3)：555-558.
10Andrulionyte L，Peltola P，Jean-Louis，et al．Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARγ2 predict the conversion from impaired glucose tolerance to type 2 diabetes the STOP-NIDDM Trial[J]．Diabetes,2006．55:2148-2152.
